Nektar Therapeutics chief R&D officer sells $48,048 in stock By Investing.com - Stock Watch Index

Nektar Therapeutics chief R&D officer sells $48,048 in stock By Investing.com

December 20, 2024

Nektar Therapeutics chief R&D officer sells $48,048 in stock

Search

RECENT PRESS RELEASES

World Liberty Financial Expands Ethereum Investments in DeFi

2024-12-21T00:17:56-08:00December 21, 2024|

Dave Portnoy Says He Owns $1.5 Million Bitcoin, $1.3 Million XRP: ‘Bet It And Set It, Not Trading’

2024-12-20T23:19:16-08:00December 20, 2024|

Climate, migration and conflict mix to create ‘deadly’ intense tropical storms like Chido

2024-12-20T23:19:01-08:00December 20, 2024|

Biden can still help preserve the environment in his final days

2024-12-20T23:18:49-08:00December 20, 2024|

Photronics EVP Christopher Progler sells $1.57m in stock By Investing.com

2024-12-20T23:18:37-08:00December 20, 2024|

ZipRecruiter’s chief legal officer Ryan Sakamoto sells $8,125 in stock By Investing.com

2024-12-20T23:18:36-08:00December 20, 2024|

Related Post